Impact Factor
3.77
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.23
2,246 total citations
h5-index
39
h5 depth signal
Cited share
78.0%
589 of 755
Total citations
2,246
Citation footprint
Metric signal
3.41
External metric anchor
Self-citation
2.0%
44 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
1,177
Spain
1,049
United States
163
Iran
109
Italy
109
Citing Fields of Research
Oncology
995
Immunology
475
Lung Cancer
399
Breast Cancer
395
Liver & Colon Cancer
346
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,873
Articles tracked across the journal lifetime
Indexed publication set
755
589 cited publications
Last 12 months
502
41.8 publications/month
Open access share
26.5%
133 OA publications in the last year
Leading citing country
China
1,177 citing publications
Leading citing field
Oncology
995 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v7n1, Jan./Feb. 2005-
v7n1, Jan./Feb. 2005-
Research Focus & Classification
Indexed Subjects
Oncology
Lung Cancer
Immunology
Breast Cancer
Liver & Colon Cancer
Issuing & Sponsoring Bodies
Contributor
Federación de Sociedades Españolas de Oncología
Contributor
Instituto Nacional de Cancerología de México
Broad Categories
Neoplasms
Lung Cancer
Immunology
Breast Cancer
Liver & Colon Cancer
Noncoding RNA
Prostate Cancer
Cancer, Autophagy & Apoptosis
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s12094-026-04591-3
Open DOI
Rediscovering medical humanism in the age of artificial intelligence: lessons from historical medical traditions
02
03
04
DOI 10.1007/s12094-026-04539-7
Open DOI
Exploring uncertainties in melanoma management: a Spanish multidisciplinary Delphi consensus
Purpose: Melanoma is a highly metastatic tumor responsible for 90% of skin cancer deaths. Despite established clinical guidelines, certain areas of its management in Spain remain heterogeneous, particularly in complex scenarios such as n...
05
DOI 10.1007/s12094-026-04565-5
Open DOI
Value and research advances of ctDNA in perioperative therapy for non-small cell lung cancer
Perioperative treatment plays an increasingly important role in improving outcomes for patients with resectable non-small cell lung cancer (NSCLC). Circulating tumor DNA (ctDNA) offers a new perspective for optimizing individualized peri...
06
07
DOI 10.1007/s12094-026-04586-0
Open DOI
Genetic signatures of lung cancer: association and biomarker potential of EGFR, KRAS, and HER2 polymorphisms
08
DOI 10.1007/s12094-026-04588-y
Open DOI
MACC1 in colorectal cancer: a claim-level evidence audit from metastasis driver to proposed microenvironmental regulator
09
DOI 10.1007/s12094-026-04555-7
Open DOI
Correction: SEOM–GEMCAD–TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025)
10
DOI 10.1007/s12094-026-04578-0
Open DOI
SEOM-GGCC clinical guidelines for the prophylaxis of infectious diseases in patients with cancer (UPDATE 2026)
Bibliographical & Catalog Notes
Title from cover.
Latest issue consulted: Vol. 7, no. 4 (May 2005).
Print issues ceased with v. 17 (2015)
Also issued online.
Text in English or Spanish, with summaries in either or both languages.
Published also in Mexico with the same title and content, but different advertisements.
v. 7, no. 1 (Jan-Feb. 2005)20050727 Notice published Printed on acid-free paper